GRN was previously reported to be expressed by CLL cells and upregulated in prognostically less favorable ZAP70+ CD38+ compared to ZAP70− CD38− CLL cells in cDNA microarray studies performed with CLL cell preparations that exhibited >93% CD19+ cells [65,93]. This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.